Lv3
250 积分 2022-06-06 加入
Antibody–drug conjugates for non-muscle invasive bladder cancer: current status and future development
5个月前
已完结
HER2-targeted therapies — a role beyond breast cancer
5个月前
已完结
HER2-directed therapy improves urothelial cancer outcomes
5个月前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
5个月前
已完结
Muscle-Invasive Bladder Cancer: A Watershed Moment
7个月前
已完结
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
9个月前
已完结